Disubstituted diaryl diselenides inhibit [3H]-serotonin uptake in rats

Neurotoxicity Research

Volumn 15, Issue 1, 2009, Pages 57-61

  Borges, V C ^a   Savegnago, L ^a   Dadalt, G ^a   Nogueira, Cristina Wayne ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Monoamine oxidase; Platelets; Selenium; Serotonin uptake; Synaptosomes

Indexed keywords

3 TRIFLUOROMETHYL DIPHENYL DISELENIDE; 4 METHOXY DIPHENYL DISELENIDE; ANTIDEPRESSANT AGENT; DIPHENYL DISELENIDE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ERYTHROCYTE; EXPERIMENTAL RAT; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE;

ANALYSIS OF VARIANCE; ANIMALS; BENZENE DERIVATIVES; BLOOD PLATELETS; BRAIN; MALE; ORGANOSELENIUM COMPOUNDS; RATS; RATS, WISTAR; SEROTONIN; SYNAPTOSOMES; TISSUE DISTRIBUTION; TRITIUM;

RATTUS;

EID: 70349728615     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-009-9005-5     Document Type: Article

References (34)

1. Anderson GM, Czarkowski K, Ravski N, Epperson CN (2004) Platelet serotonin in newborns and infants: Ontogeny, heritability and effect of in utero exposure to selective serotonin reuptake inhibitors (SSRIs). Pediatr Res 56:418-422
2. Bolden-Watson C, Richelson E (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023-1029
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
4. Coccaro EF, Murphy DL (eds) (1990) The progress in psychiatry series. In: Serotonin in major psychiatric disorders, American Psychiatric Press, Washington, DC, 260 pp
5. Cryan JF, Page ME, Lucki I (2002) Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 436:197-205
6. Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435-451
7. Gareri P, Falconi U, De Fazio P, De Sarro G (2000) Conventional and new antidepressant drugs in the elderly. Prog Neurobiol 61:353-396
8. Hajos F (1975) An improved method for the preparation of synaptosomal fractions in high purity. Brain Res 93:485-489
9. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM (1992) Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 49:809-816
10. Lesch KP, Moessner R (1998) Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 44:179-192
11. Lesch KP, Wolozin BL, Murphy DL, Riederer P (1993) Primary structure of the human platelet serotonin uptake site: Identity with brain serotonin transporter. J Neurochem 6:2319-2322
12. Licinio J, Wong M (2001) Cytokines in the brain: From localization and function to clinical implications. Neuroimmune Biol 1:365-371
13. Luchese C, Brandäo R, Oliveira R, Nogueira CW, Santos FW (2007) Efficacy of diphenyl diselenide against cerebral and pulmonary damage induced by cadmium in mice. Toxicol Lett 173:181-190
14. May JM, Mendiratta S, Qu Z, Loggins E (1999) Vitamin C recycling and function in human monocytic U-937 cells. Free Radic Biol Med 26:1513-1523
15. Meotti FC, Borges VC, Zeni G, Rocha JBT, Nogueira CW (2003) Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and Ebselen for rats and mice. Toxicol Lett 143:9-16
16. Meotti FC, Stangherlin EC, Nogueira CW, Rocha JBT (2004) Protective role of aryl and alkyl diselenides on lipid peroxidation. Environ Res 52:56-63
17. Millan MJ (2004) The role of monoamines in the actions of established and "novel" antidepressant agents: A critical review. Eur J Pharmacol 500:371-384
18. Murphy DL, Andrews AM, Wichems CH, Li Q, Tohda M, Greenberg B (1998) Brain serotonin neurotransmission: An overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. J Clin Psychiatry 59:4-12
19. Nestler EJ, Gould E, Manji H (2002) Preclinical models: Status of basic research in depression. Biol Psychiatry 52:503-528
20. Nogueira CW, Quinhones EB, Jung EAC, Zeni G, Rocha JBT (2003a) Anti-inflammatory and antinociceptive activity of diphenyl diselenide. Inflamm Res 52:56-63
21. Nogueira CW, Meotti FC, Curte E, Pilissão C, Zeni G, Rocha JBT (2003b) Investigations into the potential neurotoxicity induced by diselenides in mice and rats. Toxicology 183:29-37
22. Orallo F (2006) Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem 13:87-98
23. Paulmier C (ed) (1986) In: Selenium reagents and intermediates in organic synthesis, Pergamon, Oxford
24. Pinto LG, Jesse CR, Nogueira CW, Savegnago L (2008) Evidence for the involvement of glutamatergic and GABAergic systems and protein kinase A pathway in the antinociceptive effect caused by p-methoxy-diphenyl diselenide in mice. Pharmacol Biochem Behav 88:487-496
25. Pletcher A (1991) Platelets as peripheral models for neuropsychiatry: A brief review. In: Racagni G, Brunello N, Fukuda T (eds) Biological psychiatry. Excerpta Medica, Amsterdam, pp 354-359
26. Rossato JI, Ketzer LA, Centurião FB, Silva SJN, Lüdtke DS, Zeni G, Braga AL, Rubin MA, Rocha JBT (2002) Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain. Neurochem Res 27:297-303
27. Savegnago L, Pinto LG, Jesse CR, Alves D, Rocha JBT, Nogueira CW, Zeni G (2007a) Antinociceptive properties of diphenyl diselenide: Evidences for the mechanism of action. Eur J Pharmacol 555:129-138
28. Savegnago L, Jesse CR, Pinto LG, Alves D, Rocha JBT, Nogueira CW, Zeni G (2007b) Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog Neuropsychopharmacol Biol Psychiatry 31:1261-1269
29. Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Barancelli DA, Nogueira CW, Zeni G (2008) Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: Involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88:418-426
30. Schwartz K, Weizman A, Rehavi M (2005) Decreased platelet vesicular monoamine transporter density in habitual smokers. Eur Neuropsychopharmacol 15:235-238
31. Ulak G, Mutlu O, Akar FY, Komsuoǧlu FI, Tanyeri P, Erden BF (2008) Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats. Pharmacol Biochem Behav 90:563-568
32. Wise TN, Mann LS (1996) Utilization of pain medications in hospitalized psychiatric patients. Gen Hosp Psychiatry 18:422-425
33. Yáñez M, Fraiz N, Cano E, Orallo F (2006) Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun 344:688-695
34. Zasso FB, Gonçales CEP, Jung EAC, Araldi D, Zeni G, Rocha JBT, Nogueira CW (2005) On the mechanisms involved in antinociception induced by diphenyl diselenide. Environ Toxicol Pharmacol 19:283-289